dc.contributor.author |
Yesilkaya, S |
|
dc.contributor.author |
Acikel, C |
|
dc.contributor.author |
Fidanci, BE |
|
dc.contributor.author |
Polat, A |
|
dc.contributor.author |
Sozeri, B |
|
dc.contributor.author |
Ayaz, NA |
|
dc.contributor.author |
Makay, BB |
|
dc.contributor.author |
Simsek, D |
|
dc.contributor.author |
Akinci, N |
|
dc.contributor.author |
Ozcelik, G |
|
dc.contributor.author |
Kavukcu, S |
|
dc.contributor.author |
Emre, S |
|
dc.contributor.author |
Donmez, O |
|
dc.contributor.author |
Delibas, A |
|
dc.contributor.author |
Yuksel, S |
|
dc.contributor.author |
Berdeli, A |
|
dc.contributor.author |
Poyrazoglu, H |
|
dc.contributor.author |
Saldir, M |
|
dc.contributor.author |
Fidanci, K |
|
dc.contributor.author |
Cakar, N |
|
dc.contributor.author |
Peru, H |
|
dc.contributor.author |
Bakkaloglu, S |
|
dc.contributor.author |
Tabel, Y |
|
dc.contributor.author |
Sari, O |
|
dc.contributor.author |
Aydogan, U |
|
dc.contributor.author |
Ozenc, S |
|
dc.contributor.author |
Basbozkurt, G |
|
dc.contributor.author |
Unsal, E |
|
dc.contributor.author |
Kasapcopur, O |
|
dc.contributor.author |
Gok, F |
|
dc.contributor.author |
Ozen, S |
|
dc.contributor.author |
Demirkaya, E |
|
dc.date.accessioned |
2022-10-13T11:46:41Z |
|
dc.date.available |
2022-10-13T11:46:41Z |
|
dc.date.issued |
2015 |
|
dc.identifier.uri |
http://hdl.handle.net/11616/79611 |
|
dc.description.abstract |
Objective. To develop and assess the validity and reliability of an adherence scale concerning medical treatment in paediatric FMF patients. |
|
dc.description.abstract |
Methods. The Medication Adherence Scale in FMF Patients (MASIF) is a 18-item questionnaire that evaluates adherence to medication in four domains. Validation of the instrument was accomplished in paediatric FMF patients (aged 2-18 years) under medication at least for 6 months. The first step was to build up the scale through qualitative approach (with interviews using semi-structured questions). Validation analyses included assessment of feasibility, face and content validity; construct validity, internal consistency and test-retest reliability. |
|
dc.description.abstract |
Results. One hundred and fifty patients with FMF were enrolled in the study. The mean age of the patients was 11.11 +/- 4.02 years and 48.7% of them were male. The MASIF was found to be feasible and valid for both face and content. It correlated with the Morisky Medication Adherence Scale as a gold standard thereby demonstrating good construct validity (r=0.5 15, p<0.001). Assessment of content validity identified four subscales. The internal consistency, Cronbach's alpha was 0.728. There was a positive and significant correlation between test and retest scores (r-0.843; p<0.001). Also, a significant correlation between parents' and children's reports (r=0.781, p<0.001). |
|
dc.description.abstract |
Conclusion. Based on these results, the use of this scale to assess and follow up the adherence to treatment in paediatric FMF patients under medical treatment is recommended. |
|
dc.description.abstract |
C1 [Yesilkaya, S.; Sari, O.; Aydogan, U.; Ozenc, S.] Gulhane Mil Med Acad, Dept Family Med, Ankara, Turkey. |
|
dc.description.abstract |
[Acikel, C.] Gulhane Mil Med Fac, Dept Biostat, TR-06018 Ankara, Turkey. |
|
dc.description.abstract |
[Fidanci, B. E.] Gulhane Mil Med Acad, Sch Nursing, Ankara, Turkey. |
|
dc.description.abstract |
[Polat, A.; Simsek, D.; Saldir, M.; Fidanci, K.; Basbozkurt, G.] Gulhane Mil Med Fac, Dept Paediat, Ankara, Turkey. |
|
dc.description.abstract |
[Sozeri, B.; Berdeli, A.] Ege Univ, Fac Med, Paediat Rheumatol, Izmir, Turkey. |
|
dc.description.abstract |
[Ayaz, N. A.] Kanuni Sultan Suleyman Res & Training Hosp, Paediat Nephrol Rheumatol, Istanbul, Turkey. |
|
dc.description.abstract |
[Makay, B. B.; Kavukcu, S.; Unsal, E.] Dokuz Eylul Univ Hosp, Dept Paediat, Izmir, Turkey. |
|
dc.description.abstract |
[Akinci, N.; Ozcelik, G.] Sisli Etfal Educ & Res Hosp, Dept Paediat, Istanbul, Turkey. |
|
dc.description.abstract |
[Emre, S.; Kasapcopur, O.] Istanbul Univ, Dept Paediat, Istanbul, Turkey. |
|
dc.description.abstract |
[Donmez, O.] Uludag Univ, Dept Paediat Rheumatol, Fac Med, Bursa, Turkey. |
|
dc.description.abstract |
[Delibas, A.] Akdeniz Univ, Dept Paediat, Mersin, Turkey. |
|
dc.description.abstract |
[Yuksel, S.] Pamukkale Univ, Dept Paediat, Fac Med, Denizli, Turkey. |
|
dc.description.abstract |
[Poyrazoglu, H.] Erciyes Univ, Fac Med, Dept Paediat, Kayseri, Turkey. |
|
dc.description.abstract |
[Cakar, N.] Minist Hlth, Diskapi Childrens Hosp, Paediat Nephrol, Ankara, Turkey. |
|
dc.description.abstract |
[Peru, H.] Selcuk Univ, Dept Paediat, Ankara, Turkey. |
|
dc.description.abstract |
[Bakkaloglu, S.] Gazi Univ, Dept Paediat, Ankara, Turkey. |
|
dc.description.abstract |
[Tabel, Y.] Inonu Univ, Paediat Nephrol, Malatya, Turkey. |
|
dc.description.abstract |
[Ozen, S.] Hacettepe Univ, Paediat Nephrol & Rheumatol Unit, Ankara, Turkey. |
|
dc.description.abstract |
[Gok, F.; Demirkaya, E.] Gulhane Mil Med Fac, Paediat Rheumatol Unit, Ankara, Turkey. |
|
dc.description.abstract |
[Demirkaya, E.] Gulhane Mil Med Acad, FMF Arthrit Vasculitis & Orphan Dis Res Paediat R, Ankara, Turkey. |
|
dc.source |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
|
dc.title |
Development of a medication adherence scale for familial Mediterranean |
|
dc.title |
fever (MASIF) in a cohort of Turkish children |
|